Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Accelerated Urinary Excretion of Methylmercury following Administration of Its Antidote N-Acetylcysteine Requires Mrp2/Abcc2, the Apical Multidrug Resistance-Associated Protein
Michael S. Madejczyk, David A. Aremu, Tracey A. Simmons-Willis, Thomas W. Clarkson and Nazzareno Ballatori
Journal of Pharmacology and Experimental Therapeutics July 2007, 322 (1) 378-384; DOI: https://doi.org/10.1124/jpet.107.122812
Michael S. Madejczyk
David A. Aremu
Tracey A. Simmons-Willis
Thomas W. Clarkson
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Accelerated Urinary Excretion of Methylmercury following Administration of Its Antidote N-Acetylcysteine Requires Mrp2/Abcc2, the Apical Multidrug Resistance-Associated Protein
Michael S. Madejczyk, David A. Aremu, Tracey A. Simmons-Willis, Thomas W. Clarkson and Nazzareno Ballatori
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 378-384; DOI: https://doi.org/10.1124/jpet.107.122812
Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS
Accelerated Urinary Excretion of Methylmercury following Administration of Its Antidote N-Acetylcysteine Requires Mrp2/Abcc2, the Apical Multidrug Resistance-Associated Protein
Michael S. Madejczyk, David A. Aremu, Tracey A. Simmons-Willis, Thomas W. Clarkson and Nazzareno Ballatori
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 378-384; DOI: https://doi.org/10.1124/jpet.107.122812
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement